docetaxel anhydrous has been researched along with acid phosphatase in 4 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (acid phosphatase) | Trials (acid phosphatase) | Recent Studies (post-2010) (acid phosphatase) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 24,029 | 223 | 1,701 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukata, S; Furihata, M; Inoue, K; Karashima, T; Kawada, C; Kurabayashi, A; Nomura, A; Ohtsuki, Y; Shuin, T | 1 |
| Arlen, PM; Beetham, P; Chen, C; Dahut, W; Feldman, J; Grosenbach, DW; Gulley, JL; Jones, E; Marte, J; Panicali, D; Parker, C; Pazdur, M; Schlom, J; Skarupa, L; Steinberg, SM; Tsang, KY | 1 |
| Bleuse, JP; Chapelle, A; Jacot, W; Lamy, PJ; Pouderoux, S; Romieu, G; Thezenas, S | 1 |
| Cho, NH; Choi, K; Choi, YD; Giancotti, FG; Ham, WS; Han, H; Heo, JE; Jang, WS; Lee, HH; Moon, YJ; Rha, KH | 1 |
1 trial(s) available for docetaxel anhydrous and acid phosphatase
| Article | Year |
|---|---|
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Androgens; Antigens; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Agents, Phytogenic; Cancer Vaccines; Combined Modality Therapy; Cross-Over Studies; Disease-Free Survival; Docetaxel; Glutamate Carboxypeptidase II; Glycoproteins; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Mucin-1; Mucins; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Time Factors; Treatment Outcome; Vaccination | 2006 |
3 other study(ies) available for docetaxel anhydrous and acid phosphatase
| Article | Year |
|---|---|
Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
Topics: Acid Phosphatase; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Bone Resorption; Carcinoma, Transitional Cell; Cell Line; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Docetaxel; Dose-Response Relationship, Drug; Humans; Imidazoles; Immunohistochemistry; In Situ Nick-End Labeling; Isoenzymes; Mice; Mice, Inbred BALB C; Mice, Nude; Osteoblasts; Proliferating Cell Nuclear Antigen; Tartrate-Resistant Acid Phosphatase; Taxoids; Tibia; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2005 |
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
Topics: Acid Phosphatase; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone and Bones; Breast Neoplasms; Calcium; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Collagen; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Intercellular Signaling Peptides and Proteins; Isoenzymes; Middle Aged; Neoadjuvant Therapy; Osteoprotegerin; Peptide Fragments; Prevalence; RANK Ligand; Retrospective Studies; Statistics, Nonparametric; Tartrate-Resistant Acid Phosphatase; Taxoids; TNF-Related Apoptosis-Inducing Ligand; Vitamin D; Vitamin D Deficiency | 2012 |
Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype.
Topics: Acid Phosphatase; Adenocarcinoma; Antineoplastic Agents; Biomarkers, Tumor; Docetaxel; Epithelial Cells; Gene Expression Profiling; Genomics; Humans; Male; Neoplasm Grading; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Sequence Analysis, RNA; Transcriptome | 2021 |